TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16922069

Group type: EXPERIMENTAL
Intervention: Cine magnetic resonance imaging using fast imaging employing steady-state acquisition (FIESTA) technique with parallel imaging
Number of subjects: 25
Study: 12964176

Group type: EXPERIMENTAL
Intervention: Dietary intake of amino acids (including lysine and serine)
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Dietary intake of lysine and serine
Number of subjects: 29133
Study: 11317832

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.8 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9103747

Group type: EXPERIMENTAL
Intervention: 12-session cognitive-behavioral treatment (CBT12)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 4-session computer-assisted cognitive-behavioral treatment (CBT4-CA)
Number of subjects: 18
Study: 8460755

Group type: EXPERIMENTAL
Intervention: Propofol and fentanyl combination
Number of subjects: 180

Group type: COMPARATOR
Intervention: Fentanyl alone
Number of subjects: 180

Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 180
Study: 3943741

Group type: EXPERIMENTAL
Intervention: Lincoff temporary balloon buckle procedure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cryotherapy and an episcleral radial silicone sponge explant
Number of subjects: 60
Study: 28933254

Group type: EXPERIMENTAL
Intervention: Working Memory (WM) training
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 180
Study: 27698600

Group type: EXPERIMENTAL
Intervention: Sublingual Misoprostol (400 µg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Vaginal Misoprostol (400 µg)
Number of subjects: 52
Study: 25127240

Group type: EXPERIMENTAL
Intervention: Probiotic L. rhamnosus GR‐1 and L. reuteri RC‐14 (2.5×10^9 CFU each)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Probiotic L. rhamnosus GR‐1 and L. reuteri RC‐14
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 23075805

Group type: EXPERIMENTAL
Intervention: Remnant preservation technique (study group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard technique (control group)
Number of subjects: 90
Study: 21105282

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 65
Study: 18773731

Group type: EXPERIMENTAL
Intervention: Napping
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-napping
Number of subjects: 0
Study: 15841891

Group type: EXPERIMENTAL
Intervention: Education and an educational pamphlet about the risks of glucocorticoid-induced osteoporosis, monitoring of drug therapy by pharmacists.
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual and customary care (Control group).
Number of subjects: 96
Study: 12459688

Group type: EXPERIMENTAL
Intervention: Phenylephrine 100 microg/ml
Number of subjects: 143

Group type: COMPARATOR
Intervention: Ephedrine 3 mg/ml
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Combination of phenylephrine 50 microg/ml and ephedrine 1.5 mg/ml
Number of subjects: 143
Study: 10332905

Group type: EXPERIMENTAL
Intervention: Independent apartments
Number of subjects: 303

Group type: COMPARATOR
Intervention: Staffed group homes
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Substance abuse treatment
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Clinician recommendations for group living
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Preference for independent living
Number of subjects: 303
Study: 7661160

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 1 g t.i.d.
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 0.5 g t.i.d.
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 1 g suspension t.i.d. (re-treatment)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 3 g (side effects)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 1.5 g (side effects)
Number of subjects: 59
Study: 1659570

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid pins
Number of subjects: 24

Group type: COMPARATOR
Intervention: Kirschner wires
Number of subjects: 24
Study: 7064879

Group type: EXPERIMENTAL
Intervention: Folic acid, 10 mg daily for 3 months
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (ascorbic acid, 10 mg daily for 3 months)
Number of subjects: 47
Study: 31836300

Group type: EXPERIMENTAL
Intervention: Audiovisual sexual stimulation (AVSS) during penile Doppler ultrasound (PDU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intracavernous injection (ICI) alone
Number of subjects: 40
Study: 30682573

Group type: EXPERIMENTAL
Intervention: pdC1‐INH liquid
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 30793875

Group type: COMPARATOR
Intervention: Standard-of-care (SOC) HIV services
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Food assistance
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Cash transfer
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Food and cash transfers
Number of subjects: 805
Study: 26934941

Group type: EXPERIMENTAL
Intervention: Gradual withdrawal of remifentanil infusion
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Abrupt withdrawal of remifentanil infusion
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 24611922

Group type: EXPERIMENTAL
Intervention: Interviewer-administered method
Number of subjects: 119

Group type: COMPARATOR
Intervention: Self-administered method
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 119
Study: 22044694

Group type: EXPERIMENTAL
Intervention: Polyphenon E (800 mg epigallocatechin gallate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polyphenon E
Number of subjects: 0
Study: 19680066

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 40)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 60
Study: 17553467

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (titrated from 37.5 mg to a maximum of 225 mg over 16 weeks)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study: 15037872

Group type: EXPERIMENTAL
Intervention: Candesartan 8-16 mg daily
Number of subjects: 4937
Study: 12184416

Group type: EXPERIMENTAL
Intervention: Resected MTA (Group 1)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: MTA placed as a retrograde root-end filling material (Group 2)
Number of subjects: 46
Study: 9658723

Group type: EXPERIMENTAL
Intervention: Microsatellite analysis
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Microsatellite markers D2S123 and D18S58
Number of subjects: 41
Study: 7806690

Group type: EXPERIMENTAL
Intervention: Fluvoxamine + Haloperidol + Benztropine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 4
Study: 2562912

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 55715

Group type: EXPERIMENTAL
Intervention: Oral disodium cromoglycate (2 g/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30064262

Group type: EXPERIMENTAL
Intervention: Underwater treadmill exercise for 30 minutes/day, three times/week for four weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Daily quadriceps exercise at home for 30 minutes (control group)
Number of subjects: 80
Study: 27979820

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Befriending
Number of subjects: 96
Study: 25805451

Group type: EXPERIMENTAL
Intervention: Dose delays and reductions
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Symptom interference
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Severity of pain
Number of subjects: 385
Study: 23673144

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 33

Group type: COMPARATOR
Intervention: Valproate
Number of subjects: 33
Study: 21375445

Group type: EXPERIMENTAL
Intervention: Psychological therapies (relaxation training, biofeedback, multimodal cognitive-behavioral therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypnosis and acceptance and commitment therapy
Number of subjects: 0
Study: 19479152

Group type: EXPERIMENTAL
Intervention: TENS with electrode placement on acupuncture points
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TENS on non-acupuncture points along the same peripheral nerve
Number of subjects: 45

Group type: COMPARATOR
Intervention: No stimulation (control)
Number of subjects: 45
Study: 17087847

Group type: EXPERIMENTAL
Intervention: Vital capacity manoeuvre (VCM) followed by PEEP of 8 cm H2O
Number of subjects: 52

Group type: COMPARATOR
Intervention: PEEP of 8 cm H2O
Number of subjects: 52
Study: 16330291

Group type: EXPERIMENTAL
Intervention: RSG/MET (4 mg/2 g per day, escalated to 8 mg/2 g per day)
Number of subjects: 568

Group type: COMPARATOR
Intervention: MET (2.5 g/d, escalated to 3 g/d)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: RSG/MET
Number of subjects: 568

Group type: COMPARATOR
Intervention: MET
Number of subjects: 568
Study: 11777672

Group type: EXPERIMENTAL
Intervention: Stage-matched/tailored materials (Group 3)
Number of subjects: 1026

Group type: COMPARATOR
Intervention: Usual care (Group 1)
Number of subjects: 1026

Group type: COMPARATOR
Intervention: Standard materials (Group 2)
Number of subjects: 1026
Study: 9931670

Group type: EXPERIMENTAL
Intervention: Endarterectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endovascular therapy
Number of subjects: 0
Study: 8137477

Group type: EXPERIMENTAL
Intervention: PSK with 5‐FU (n = 15)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: lentinan with 5‐FU (n = 15)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: OK‐432 with 5‐FU (n = 12)
Number of subjects: 58

Group type: COMPARATOR
Intervention: 5‐FU alone (n = 16)
Number of subjects: 58
Study: 2737799

Group type: EXPERIMENTAL
Intervention: sustained-release capsule with breakfast
Number of subjects: 12

Group type: COMPARATOR
Intervention: sustained-release capsule in fasting state
Number of subjects: 12

Group type: COMPARATOR
Intervention: tablet form
Number of subjects: 12
Study: 30325282

Group type: EXPERIMENTAL
Intervention: Deep Learning (DL) model for breast density assessment
Number of subjects: 5741
Study: 28558789

Group type: EXPERIMENTAL
Intervention: Active tRNS during reaching training
Number of subjects: 4

Group type: COMPARATOR
Intervention: Sham tRNS during reaching training
Number of subjects: 4
Study: 24907560

Group type: EXPERIMENTAL
Intervention: Repair
Number of subjects: 28

Group type: COMPARATOR
Intervention: Replacement
Number of subjects: 28
Study: 24099237

Group type: EXPERIMENTAL
Intervention: 40 mg oral mosapride
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 22141334

Group type: EXPERIMENTAL
Intervention: Neuromuscular exercise program
Number of subjects: 100

Group type: COMPARATOR
Intervention: Quadriceps strengthening program
Number of subjects: 100
Study: 19783538

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 30 mg kg(‐1) bolus + 10 mg kg(‐1) h(‐1) continuous infusion (Mg 30 group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 45 mg kg(‐1) bolus + 15 mg kg(‐1) h(‐1) continuous infusion (Mg 45 group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (i.v. saline)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (both Mg 30 and Mg 45 groups)
Number of subjects: 72
Study: 12531751

Group type: EXPERIMENTAL
Intervention: Bone‐patellar tendon‐bone graft with metal interference screw fixation
Number of subjects: 99

Group type: COMPARATOR
Intervention: Double‐looped hamstring tendons with metal plate fixation
Number of subjects: 99
Study: 9922639

Group type: EXPERIMENTAL
Intervention: Wellness intervention (N = 211)
Number of subjects: 823

Group type: COMPARATOR
Intervention: Historical control group (N = 413)
Number of subjects: 823

Group type: COMPARATOR
Intervention: No wellness intervention (N = 147)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: High-risk population (N = 52)
Number of subjects: 823
Study: 7781139

Group type: EXPERIMENTAL
Intervention: Hepsulfam at 800 mg/m2
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hepsulfam at 640 mg/m2
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hepsulfam infused over 30 min
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hepsulfam infused over 2 h
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hepsulfam at 480 mg/m2
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hepsulfam at doses > or = 640 mg/m2
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell support
Number of subjects: 21
Study: 2332564

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (0.4 mg per day)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Oral budesonide (1.4 mg per day)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 7010511

Group type: EXPERIMENTAL
Intervention: Intra-articular steroid therapy (20 mg of triamcinalone hexacetonide)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 31371386

Group type: EXPERIMENTAL
Intervention: Weekly retraining (1-month group)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Every 3-month retraining (3-month group)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no retraining)
Number of subjects: 28
Study: 28107234

Group type: EXPERIMENTAL
Intervention: Acrylic cage
Number of subjects: 64

Group type: COMPARATOR
Intervention: PEEK cage
Number of subjects: 64
Study: 26121832

Group type: EXPERIMENTAL
Intervention: Composite acoustic therapy (personalized) for the first 30 days, followed by music therapy for the next 31-90 days.
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no sound therapy).
Number of subjects: 96
Study: 23433878

Group type: EXPERIMENTAL
Intervention: S+ (suction)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: AF (air flushing)
Number of subjects: 81
Study: 21457214

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0·05% ointment (n = 30)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0·1% ointment (n = 31)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 114
Study: 19587362

Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg once daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combination of aliskiren and irbesartan
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 16999946

Group type: EXPERIMENTAL
Intervention: 80 mg of simvastatin
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 15083439

Group type: EXPERIMENTAL
Intervention: Functional task practice (FT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Strength training (ST)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 64
Study: 11398568

Group type: EXPERIMENTAL
Intervention: Strategies to overcome barriers to participation in research
Number of subjects: 0
Study: 9796243

Group type: EXPERIMENTAL
Intervention: Pressure-regulated Volume Control (PRVC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Volume Controlled ventilation (VC)
Number of subjects: 9
Study: 7816516

Group type: EXPERIMENTAL
Intervention: Enteral feeding
Number of subjects: 8

Group type: COMPARATOR
Intervention: Parenteral nutrition
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both enteral and parenteral feeding
Number of subjects: 8
Study: 29196578

Group type: EXPERIMENTAL
Intervention: Quinidine (300 mg/d)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Quinidine (900 mg/d and 600 mg/d)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Quinidine
Number of subjects: 6
Study: 26603881

Group type: EXPERIMENTAL
Intervention: Prebiotic (50% inulin and 50% fructo-oligosaccharide), 6 g twice daily from 1 week before to 3 weeks after RT
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (6 g maltodextrin twice daily from 1 week before to 3 weeks after RT)
Number of subjects: 38
Study: 25464565

Group type: EXPERIMENTAL
Intervention: D‐methionine tablets
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study: 22540883

Group type: EXPERIMENTAL
Intervention: Exenatide + metformin
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo + metformin
Number of subjects: 174
Study: 20822421

Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 175

Group type: COMPARATOR
Intervention: Thal fundoplication
Number of subjects: 175
Study: 18990592

Group type: EXPERIMENTAL
Intervention: Remote endarterectomy (RSFAE)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Supragenicular bypass surgery
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Venous grafts
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Prosthetic grafts
Number of subjects: 116
Study: 16960175

Group type: EXPERIMENTAL
Intervention: 800 IU vitamin D3/d for 2 years, then increased to 2000 IU/d
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 14738835

Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide (Xtra White)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 18% carbamide peroxide (Colgate Simply White)
Number of subjects: 20
Study: 11408327

Group type: EXPERIMENTAL
Intervention: Area Dentata (AD) in autistic patients
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Combined area of the subiculum and CA1-CA3 (CAS) in autistic patients
Number of subjects: 59

Group type: COMPARATOR
Intervention: Healthy normal controls
Number of subjects: 59
Study: 9416862

Group type: EXPERIMENTAL
Intervention: Juvenile rheumatoid arthritis (JRA) cases
Number of subjects: 50
Study: 8120156

Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 3616532

Group type: EXPERIMENTAL
Intervention: Regular home visits over a period of three years
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not contacted until the conclusion of the study period)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Regular home visits
Number of subjects: 25
Study: 31667992

Group type: EXPERIMENTAL
Intervention: Restrictive protocol
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Thromboelastometry-guided protocol
Number of subjects: 57

Group type: COMPARATOR
Intervention: Coagulogram-guided protocol
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Restrictive protocol vs Coagulogram-guided arm
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Restrictive protocol vs Thromboelastometry-guided arm
Number of subjects: 57

Group type: COMPARATOR
Intervention: Thromboelastometry-guided vs Coagulogram-guided arm
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 57
Study: 29845932

Group type: EXPERIMENTAL
Intervention: Standardised supported self-management (SSM)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Observational study measures
Number of subjects: 82
Study: 27918443

Group type: EXPERIMENTAL
Intervention: Olive Leaf Extract (OLE) 20 mL daily for 8 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 29
Study: 23962455

Group type: EXPERIMENTAL
Intervention: Abatacept (125 mg weekly)
Number of subjects: 646

Group type: COMPARATOR
Intervention: Adalimumab (40 mg bi-weekly)
Number of subjects: 646
Study: 22648709

Group type: EXPERIMENTAL
Intervention: Alginate-based preload supplement (15 g fiber)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo preload supplement
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups (ITT analysis)
Number of subjects: 96
Study: 20697939

Group type: EXPERIMENTAL
Intervention: Acupuncture at acupoints Zhongwan (CV 12), bilateral Zusanli (ST36), Sanyinjiao (SP6), and Neiguan (PC6), once a day for 1 week, with intervals of 2-3 days between courses, for a total duration of 6 weeks.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Omeprazole 20 mg twice a day and 20 mg mosapride thrice a day for a total duration of 6 weeks.
Number of subjects: 60
Study: 17996436

Group type: EXPERIMENTAL
Intervention: Tiotropium 5 microg via Respimat SMI
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Tiotropium 10 microg via Respimat SMI
Number of subjects: 719

Group type: COMPARATOR
Intervention: Ipratropium 36 microg pMDI QID
Number of subjects: 719

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 719
Study: 15941145

Group type: COMPARATOR
Intervention: Allicor (Allium sativum preparation) for 12 months
Number of subjects: 79
Study: 12874191

Group type: EXPERIMENTAL
Intervention: FilterWire EX
Number of subjects: 651

Group type: COMPARATOR
Intervention: GuardWire
Number of subjects: 651
Study: 10577446

Group type: EXPERIMENTAL
Intervention: Ecadotril 50 to 400 mg twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 8762732

Group type: EXPERIMENTAL
Intervention: Hexarelin (1 microgram/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GHRH-(1-29)-NH2 (1 microgram/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin with GHRH-(1-29)-NH2
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin (second bolus)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin with GHRH-(1-29)-NH2 (second bolus)
Number of subjects: 6
Study: 1678221

Group type: EXPERIMENTAL
Intervention: Histamine (1, 3.3, 10, 33, and 100 micrograms/ml) injected intradermally
Number of subjects: 15
Study: 7055526

Group type: EXPERIMENTAL
Intervention: General anaesthesia with thiopentone, fentanyl and nitrous oxide, infusion of isotonic saline solution 5ml min‐1 (Group I)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: General anaesthesia with thiopentone, fentanyl and nitrous oxide, infusion of isotonic saline solution 15 ml min‐1 (Group II)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Extradural anaesthesia (Group III)
Number of subjects: 19